Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 71 of 71 entries
View as:

Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

Phase: N/A Priority: Normal
NCT ID: NCT01585558 Org: User:
Start: 05/16/06 End: 09/18/08 Due: 09/18/09

Effect of Food and Calcium on Pharmacokinetics of a Single Dose of S-888711 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03897413 Org: User:
Start: 11/06/09 End: 12/23/09 Due: 12/23/10

A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06751017 Org: User:
Start: 12/17/24 End: 02/24/25 Due: 02/24/26

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants

Phase: N/A Priority: Normal
NCT ID: NCT04335539 Org: User:
Start: 08/21/20 End: 02/06/23 Due: 02/06/24

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT01129024 Org: User:
Start: 04/29/10 End: 06/30/11 Due: 06/30/12

A Clinical Study to Evaluate the Safety of Ospemifene

Phase: N/A Priority: Normal
NCT ID: NCT00566982 Org: User:
Start: 10/31/07 End: 07/31/09 Due: 07/31/10

Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01154348 Org: User:
Start: 06/30/10 End: 12/31/10 Due: 12/31/11

A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05395104 Org: User:
Start: 05/24/22 End: 07/13/22 Due: 07/13/23

A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03315793 Org: User:
Start: 12/04/17 End: 11/08/19 Due: 11/08/20

Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01651871 Org: User:
Start: 07/31/12 End: 05/31/13 Due: 05/31/14

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01240759 Org: User:
Start: 10/31/10 End: 01/31/12 Due: 01/31/13

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00723190 Org: User:
Start: 01/31/08 End: 06/30/10 Due: 06/30/11

Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls

Phase: N/A Priority: Normal
NCT ID: NCT07018492 Org: User:
Start: 07/07/25 End: 12/31/25 Due: 12/31/26

Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device

Phase: N/A Priority: Normal
NCT ID: NCT04631354 Org: User:
Start: 11/09/20 End: 12/21/20 Due: 12/21/21

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Phase: N/A Priority: Normal
NCT ID: NCT06086626 Org: User:
Start: 03/14/24 End: 03/31/25 Due: 03/31/26

A Study to Assess S-309309 in Healthy and Obese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05247970 Org: User:
Start: 01/04/22 End: 11/01/22 Due: 11/01/23

Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01993940 Org: User:
Start: 11/04/13 End: 06/09/15 Due: 06/09/16

A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00703573 Org: User:
Start: 05/31/08 End: 12/31/09 Due: 12/31/10

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01126970 Org: User:
Start: 04/30/10 End: 02/28/11 Due: 02/28/12

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

Phase: N/A Priority: Normal
NCT ID: NCT04215991 Org: User:
Start: 02/19/20 End: 09/17/24 Due: 09/17/25

Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])

Phase: N/A Priority: Normal
NCT ID: NCT06717438 Org: User:
Start: 03/01/27 End: 01/31/30 Due: 01/31/31